The first COVID-19 case in Sudan was announced on March 13th, 2020. 1835 deaths were recorded as of February 7th, 2021. 800,000 doses of the Oxford-AstraZeneca vaccine were allocated to Sudan through COVAX in March 2021. However, multiple challenges exist in vaccinating the Sudanese population, ranging from an inadequate cold chain system to low acceptance rates of COVID-19 vaccination among the Sudanese population. Economic crises, high inflation rates and long-standing economic sanctions have also negatively impacted the healthcare system in Sudan as a result of deprivation of access to research and development funding.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522678 | PMC |
| http://dx.doi.org/10.1016/j.puhip.2021.100205 | DOI Listing |
Publication Analysis
Top Keywords
sudanese population
8
fight covid-19
4
covid-19 pandemic
4
pandemic vaccination
4
vaccination challenges
4
sudan
4
challenges sudan
4
sudan covid-19
4
covid-19 case
4
case sudan
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!